Background {#sec1}
==========

The kinetic glomerular filtration rate (GFR~K~) is an attempt to track kidney function even while the serum or plasma creatinine concentration (\[*Cr*\]) is changing over time. Essentially, GFR~K~ is a creatinine clearance (CL~cr~) rate, and all clearances are based on the fundamental clearance equation. In the case of creatinine, it can be written as $\text{CL}_{\text{cr}}\  = \ \frac{U_{Cr} \times V}{P_{Cr}}$, where *U*~*Cr*~ is urinary \[*Cr*\], *V* is urine flow rate (thereby incorporating time), and *P*~*Cr*~ is plasma \[*Cr*\].[@bib1] *U*~*Cr*~×*V* is usually measured from a 24-hour urine collection, but the duration could be longer or shorter. This clearance equation is always valid, in theory. It is easy to apply when \[*Cr*\] is basically stable, as in chronic kidney disease, but how is it applied when the \[*Cr*\] is evolving over time, such as in acute kidney injury (AKI) or renal recovery? The equation calls for only one creatinine value, but what value is chosen in the nonsteady state when there is a whole range of \[*Cr*\] values? We hypothesize that there must exist a correct \[*Cr*\], probably some "average" value, that will make the basic clearance formula behave identically to any kinetic GFR equation.

Mass Balance Principle And The Average {#sec2}
======================================

At the heart of kinetic analysis, a pair of \[*Cr*\]s separated by a known interval comprises the basic data that are reported by the clinical laboratory. Connecting the \[*Cr*\] end points is a trajectory that is likely to be smooth and continuous. What is the \[*Cr*\]s' average during that time? If a \[*Cr*\] trajectory is thought to be linear, one could compute the simple mean value of the \[*Cr*\] end points to use for the denominator of $\frac{U_{Cr} \times V}{P_{Cr}}$. Effectively, that is what was done in 2013 for the "algebraic" GFR~K~.[@bib2] By 2018, the \[*Cr*\] trajectory was being modeled based on the principle of mass balance, which asserts that the creatinine generation rate minus the creatinine excretion rate must equal the creatinine change rate. In mathematical terms, this translates into:$$Gen\  - \ GFR_{K} \cdot \left\lbrack {Cr} \right\rbrack_{t}\  = \ \frac{\text{d}}{\text{d}t}\left( {\left\lbrack {Cr} \right\rbrack_{t} \cdot V_{t}} \right)$$where creatinine generation rate (*Gen*) is assumed to be constant, excretion rate is given by a GFR~K~ times the ambient \[*Cr*\] as a function of time (\[*Cr*\]~*t*~), and the instantaneous rate of creatinine change is described by the derivative with respect to time $(\frac{\text{d}}{\text{d}t})$ of the ambient creatinine mass (\[*Cr*\]~*t*~⋅*V*~*t*~). Further, the volume as a function of time (*V*~*t*~) starts at an initial volume (*V*~0~) and changes at a fixed rate $\left( \frac{\text{Δ}V}{\text{Δ}t} \right)$ throughout some time (*t*) between \[*Cr*\] measurements, so that $V_{t} = V_{0}\  + \ \frac{\text{Δ}V}{\text{Δ}t}t$. The GFR~K~ itself can change during the period, notably while kidney function is decreasing steeply as in severe AKI. All of the evolving GFR~K~s can be replaced by a single (and effectively constant) average value for that period. This replacement yields an identical result, as if the average GFR~K~ were acting on the \[*Cr*\] trajectory to give a total creatinine excretion and overall rate of \[*Cr*\] change.

As previously shown,[@bib3], [@bib4] the solution to differential equation [(1)](#fd1){ref-type="disp-formula"} is:$$\left\lbrack {Cr} \right\rbrack_{t}\  = \ \left\lbrack {Cr} \right\rbrack_{0}\  + \ \left( {\frac{Gen}{GFR_{K} + \frac{\text{Δ}V}{\text{Δ}t}}\  - \ \left\lbrack {Cr} \right\rbrack_{0}} \right)\left. \cdot\lbrack{1\  - \ \left( \frac{V_{0}}{V_{0}\  + \ \frac{\text{Δ}V}{\text{Δ}t}t}) \right.^{({1\  + \ \frac{GFR_{K}}{\frac{\text{Δ}V}{\text{Δ}t}}})}} \right\rbrack$$

If equation [(2)](#fd2){ref-type="disp-formula"} models the \[*Cr*\] trajectory, which is clearly nonlinear, the mean value of the 2 \[*Cr*\] end points is not the correct average. Instead, we must calculate the average of all \[*Cr*\]s traversed during the trajectory over some interval, using calculus. We postulate that if this "true average" is used in the denominator of $\frac{U_{Cr} \times V}{P_{Cr}}$, the resulting CL~cr~ will equal the GFR~K~ as calculated directly from equation [(2)](#fd2){ref-type="disp-formula"}.

Rationale for the Average {#sec2.1}
=========================

Any continuous \[*Cr*\] trajectory obeying the mass balance differential equation should have a single middle value that represents its exact average; call it $\overline{P_{Cr}}$. When the horizontal line $y = \overline{P_{Cr}}$ is superimposed on a graph of \[*Cr*\]~*t*~ over some interval \[*a*, *b*\], it will divide the \[*Cr*\]~*t*~ curve such that the area of \[*Cr*\]~*t*~ below the $\overline{P_{Cr}}$ average line balances out the area of \[*Cr*\]~*t*~ above the average line ([Fig 1](#fig1){ref-type="fig"}). To be practical, we let the interval run from 0 to *T*, where *T* is the total time between 2 measured \[*Cr*\]s. In a way, every pair of consecutive \[*Cr*\] data resets the clock, and the duration between \[*Cr*\] end points is then simply *T*. Because the signed areas (above) add up to zero, an integral can be written as:$$\int_{0}^{T}{\left( {\left\lbrack {Cr} \right\rbrack_{t}\  - \ \overline{P_{Cr}}} \right)\text{d}t\  = \ 0}$$Figure 1True average creatinine concentration (\[Cr\]) line divides a \[Cr\] versus time graph into equal areas. The red curve depicts the evolution of \[Cr\] (mg/dL) over time (days) if the glomerular filtration rate decreased from 100 to 10.104 mL/min and the volume kept increasing by 3.6 L/d. In 10 days, \[Cr\] has a calculus-average value of 5.099 mg/dL, which does not have to occur at the halfway point in time. The blue horizontal line *y* = 5.099 divides the graph such that the signed areas between the curve and the line cancel each other out; that is, the blue area equals the purple area. Because the \[Cr\] trajectory had time to significantly curve away from the imaginary (dashed) line connecting the 2 \[Cr\] end points, the true average \[Cr\] (5.099 mg/dL) must be used instead of the linear average \[Cr\] (3.727 mg/dL).

Integration is linear, and the integral ${\int_{0}^{T}\overline{P_{Cr}}}\text{d}t$ can be factored out as $\overline{P_{Cr}}{\int_{0}^{T}{\text{d}t}}$ because $\overline{P_{Cr}}$ is a constant. Solving equation [(3)](#fd3){ref-type="disp-formula"} gives $\overline{P_{Cr}} = \frac{\int_{0}^{T}\left\lbrack {Cr} \right\rbrack_{t}\text{d}t}{\int_{0}^{T}\text{d}t}$. Moreover, because ${\int_{0}^{T}{\text{d}t}}\  = \ T$, we have:$$\overline{P_{Cr}}\  = \ \frac{\int_{0}^{T}\left\lbrack {Cr} \right\rbrack_{t}\text{d}t}{T}$$

Proving That the True Average \[Cr\] Fulfills the Differential Equation {#sec2.17}
=======================================================================

Differential equation [(1)](#fd1){ref-type="disp-formula"} was previously solved[@bib3] for \[*Cr*\]~*t*~ using the usual methods, leading to equation [(2)](#fd2){ref-type="disp-formula"}. Instead, we can first manipulate equation [(1)](#fd1){ref-type="disp-formula"} by the fundamental theorem of calculus to spawn the true average integral and gain insight into the role it plays: $\left. \frac{\text{d}}{\text{d}t}\left( {\left\lbrack {Cr} \right\rbrack_{t}V_{t}} \right)\  = \ Gen\  - GFR_{K} \cdot \left\lbrack {Cr} \right\rbrack_{t}\ \Rightarrow\ \text{d}\left( {\left\lbrack {Cr} \right\rbrack_{t}V_{t}} \right)\  = \ \left( {Gen\  - GFR_{K} \cdot \left\lbrack {Cr} \right\rbrack_{t}} \right)\text{d}t \right.$. Integrate both sides from time 0 to *T*: $\left. {\int_{0}^{T}{\text{d}\left( {\left\lbrack {Cr} \right\rbrack_{t}V_{t}} \right)}} = {\int_{0}^{T}{\left( {Gen\  - \ GFR_{K} \cdot \left\lbrack {Cr} \right\rbrack_{t}} \right)\text{d}t}}\Rightarrow\left\lbrack {Cr} \right\rbrack_{T}V_{T}\  - \ \left\lbrack {Cr} \right\rbrack_{0}V_{0} = {\int_{0}^{T}{Gen\ \text{d}t}}\  - \ {\int_{0}^{T}{GFR_{K}}} \cdot \left\lbrack {Cr} \right\rbrack_{t}\text{d}t \right.$. The left-hand \[*Cr*\]~*T*~ is now the later \[*Cr*\] end point measured by the laboratory. It is not to be confused with the right-hand \[*Cr*\]~*t*~, which is still the \[*Cr*\] as a function of time. Continuing, the right-hand side can be integrated to give $Gen \cdot T\  - GFR_{K}{\int_{0}^{T}{\left\lbrack {Cr} \right\rbrack_{t}\text{d}t}}$. Well, $\int_{0}^{T}{\left\lbrack {Cr} \right\rbrack_{t}\text{d}t}$ is the numerator of the supposed true average. From equation [(4)](#fd4){ref-type="disp-formula"} then, ${\int_{0}^{T}{\left\lbrack {Cr} \right\rbrack_{t}\text{d}t}}\  = \overline{P_{Cr}} \cdot T$. Substitute this in to get $\left\lbrack {Cr} \right\rbrack_{T}V_{T} - \left\lbrack {Cr} \right\rbrack_{0}V_{0}\  = \ Gen \cdot T\  - \ GFR_{K} \cdot \overline{P_{Cr}} \cdot T$. Finally, solve for the GFR~K~:$$GFR_{K}\  = \ \frac{Gen \cdot T\  - \ \left( {\left\lbrack {Cr} \right\rbrack_{T}V_{T}\  - \ \left\lbrack {Cr} \right\rbrack_{0}V_{0}} \right)}{\overline{P_{Cr}} \cdot T}$$

Fundamental Proof: Strengths and Flexibilities {#sec2.2}
==============================================

Assuming a constant average *GFR*~*K*~ over a given period, any \[*Cr*\] function that follows the mass balance principle will necessarily produce a $\overline{P_{Cr}}$. In the differential equation, the $\frac{\text{d}}{\text{d}t}\left( {\left\lbrack {Cr} \right\rbrack_{t}V_{t}} \right)$ term has a volume as a function of time that does not have to be linear. It can be nonlinear in the model to better reflect reality. Similarly, the *Gen* does not have to be constant; it too can vary linearly or nonlinearly. In terms of creatinine gain, another source is absorption from food,[@bib5] and that can be incorporated into the differential equation. In terms of creatinine loss, any (constant average) extrarenal clearances can be added in separately, as in (*CL*~*Extra*~ + *GFR*~*K*~)⋅\[*Cr*\]~*t*~. A fixed excretion rate independent of the ambient \[*Cr*\]~*t*~ can also be included. These optional modules enable us to model clearance more realistically, and yet they all leave $\int_{0}^{T}{\left\lbrack {Cr} \right\rbrack_{t}\text{d}t}$ intact, inserting a $\overline{P_{Cr}}$ into the final equation. Thus, $\overline{P_{Cr}}$ serves as the true divisor in $\frac{U_{Cr} \times V}{P_{Cr}}$ whenever \[*Cr*\] is changing.

Creatinine Excretion Rate {#sec2.3}
=========================

By the process of elimination, the rest of equation [(5)](#fd5){ref-type="disp-formula"} must fit the template of the basic clearance's numerator, that is, *U*~*Cr*~×*V*, also known as the creatinine excretion rate. The non-$\overline{P_{Cr}}$ portion of equation [(5)](#fd5){ref-type="disp-formula"} is, by inspection, $\frac{Gen \cdot T - \left( {\left\lbrack {Cr} \right\rbrack_{T}V_{T} - \left\lbrack {Cr} \right\rbrack_{0}V_{0}} \right)}{T}$. Logically, *Gen*⋅*T* tells us how much creatinine was generated over an interval *T*, while \[*Cr*\]~*T*~*V*~*T*~−\[*Cr*\]~0~*V*~0~ tells us the delta in creatinine mass. Creatinine generation minus the Δ creatinine equals creatinine excretion, which is *Gen* ⋅ *T* − (\[*Cr*\]~*T*~*V*~*T*~ − \[*Cr*\]~0~*V*~0~). Next, divide this by *T* to get the creatinine excretion rate, recreating the above. Technically, a *U*~*Cr*~×*V* calculated in this way is the total creatinine elimination rate, which comprises urinary excretion (glomerular filtration plus tubular secretion) but also includes nonrenal excretion and creatinine degradation/metabolic conversion.

Solving Explicitly for $\overline{\mathbf{P}_{\mathbf{C}\mathbf{r}}}$ {#sec2.4}
=====================================================================

We have all the information to derive a formula for the true average \[*Cr*\]. The following is just one of many potential formulas for $\overline{P_{Cr}}$. The variations arise depending on the root differential equation. Equation [(1)](#fd1){ref-type="disp-formula"}, used for the model, lets the volume change at a linear rate,[@bib3], [@bib4] but others may let the *Gen* change too or accommodate an extrarenal CL~cr~, etc. In any case, the $\overline{P_{Cr}}$ term will materialize, meaning that the true average \[*Cr*\] plays an inevitable role. The detailed methods ([Item S1](#appsec1){ref-type="sec"}) contain the derivation of our true average \[*Cr*\]. The result is:$$\overline{P_{Cr}}\  = \ \left\lbrack {Cr} \right\rbrack_{0}\  + \ \left( {\frac{Gen}{GFR_{K}\  + \ \frac{\text{Δ}V}{\text{Δ}t}}\  - \ \left\lbrack {Cr} \right\rbrack_{0}} \right) \cdot \left( {1\  - \ \frac{V_{0}}{T \cdot GFR_{K}}\left\lbrack {1\  - \ \left( \frac{V_{0}}{V_{0}\  + \ \frac{\text{Δ}V}{\text{Δ}t}T} \right)^{(\frac{GFR_{K}}{\frac{\text{Δ}V}{\text{Δ}t}})}} \right\rbrack} \right)$$

Equation [(6)](#fd6){ref-type="disp-formula"} gives the true average \[*Cr*\] over a generic period from 0 to *T*. To examine a special case, if \[*Cr*\]~*t*~ is stable, then for all *t* we have $\frac{Gen}{GFR_{K}\  + \ \frac{\text{Δ}V}{\text{Δ}t}} - \left\lbrack {Cr} \right\rbrack_{0}\  = \ 0$, and equation [(6)](#fd6){ref-type="disp-formula"} sensibly says that the true average is just the prevailing \[*Cr*\]~0~. That way, the kinetic GFR reduces down to the steady-state GFR when \[*Cr*\] is stable, as required.

The true average \[*Cr*\] expression in equation [(6)](#fd6){ref-type="disp-formula"} can be substituted into equation [(5)](#fd5){ref-type="disp-formula"} to complete the *U*×*V*/*P* version of the GFR~K~. Although they appear vastly different, equation [(5)](#fd5){ref-type="disp-formula"} must be identical to equation [(2)](#fd2){ref-type="disp-formula"} because they are both derived from differential equation [(1)](#fd1){ref-type="disp-formula"}. One can algebraically manipulate equation [(5)](#fd5){ref-type="disp-formula"} to become equation [(2)](#fd2){ref-type="disp-formula"}, but this approach uses brute force, is not elegant, and proves equivalence between equations [(5)](#fd5){ref-type="disp-formula"} and [(2)](#fd2){ref-type="disp-formula"} only. In contrast, a proof by the fundamental theorem of calculus is widely applicable because it acts at the level of any root differential equation, which can be made as complex as desired.

Calculating the GFR~K~: Clinical Case {#sec2.5}
=====================================

We will calculate the GFR~K~ in a sample clinical case, using the new equation [(5)](#fd5){ref-type="disp-formula"} that is based on the true average \[*Cr*\]. Its answer should be identical to the GFR~K~ from the old equation [(2)](#fd2){ref-type="disp-formula"}, that is, the gold standard, as guaranteed by our proof.

A woman in her 50s develops acute tubular necrosis, during which her \[*Cr*\] increases from 2.22 mg/dL at 04:22 to 3.49 mg/dL at 01:49 the next day. She weighs 101.4 kg, and the net of her inputs and outputs is +3,600 mL in 24 hours. The variables have the following values: \[*Cr*\]~0~ = 2.22 mg/dL, \[*Cr*\]~*T*~ = 3.49 mg/dL, *T* = 21.45 hours, *V*~0~ = 101.4 ⋅ 0.5 = 50.7 L (if the creatinine's volume of distribution is total body water),[@bib6] $\frac{\text{Δ}V}{\text{Δ}t}\  = \ \frac{3.6\ L}{24\ h}\  = \ 0.15\ \frac{\text{L}}{\text{h}}$, and $V_{T}\  = \ V_{0}\  + \ \frac{\text{Δ}V}{\text{Δ}t}T\  = \ 50.7\ \text{L}\  + \ 0.15\ \frac{\text{L}}{\text{h}} \cdot 21.45\ \text{h}\  = \ 53.9175\ \text{L}$. To get the creatinine generation rate, multiply any \[*Cr*\] by its estimated GFR as if in steady state. For this patient, $Gen\  = \ 0.88\ \frac{\text{mg}}{\text{dL}} \cdot 100\ \frac{\text{mL}}{\text{min}}\  = \ 88\ \frac{\text{mg×mL}}{\text{dL×min}}$. With all the variables assigned (except one), we can solve for *GFR*~*K*~.

Using the Gold Standard \[Cr\] Equation {#sec2.6}
=======================================

Equation [(2)](#fd2){ref-type="disp-formula"} is the direct solution to the differential equation in the case of a constant *Gen* and linear volume change. Equation [(2)](#fd2){ref-type="disp-formula"} can be rearranged to solve for the GFR~K~[@bib3]:$$GFR_{K}\  = \ \frac{Gen}{\left\lbrack {Cr} \right\rbrack_{t}}\left( {1\  - \ \frac{\left\lbrack {Cr} \right\rbrack_{t}\  - \ \left\lbrack {Cr} \right\rbrack_{0}}{\left\lbrack {Cr} \right\rbrack_{t} \cdot \left( \frac{V_{0}}{V_{0}\  + \ \frac{\text{Δ}V}{\text{Δ}t}t} \right)^{- {({1\  + \ \frac{GFR_{K}}{\frac{\text{Δ}V}{\text{Δ}t}}})}}\  - \ \left\lbrack {Cr} \right\rbrack_{0}}} \right)\  - \ \frac{\text{Δ}V}{\text{Δ}t}$$

*GFR*~*K*~ is on both sides of the equation and cannot be solved for explicitly. Nevertheless, we can ascertain *GFR*~*K*~ accurately. One technique is to graph the 2 sides of equation [(7)](#fd7){ref-type="disp-formula"} and see where they intersect. Another technique is to use Newton's method.

Graphing {#sec2.6.1}
--------

Replacing *GFR*~*K*~ in equation [(7)](#fd7){ref-type="disp-formula"} with the traditional *x*, we graph *y* = *x* and then at *t* = *T*:$$y\  = \ \frac{Gen}{\left\lbrack {Cr} \right\rbrack_{T}}\left( {1\  - \ \frac{\left\lbrack {Cr} \right\rbrack_{T}\  - \ \left\lbrack {Cr} \right\rbrack_{0}}{\left\lbrack {Cr} \right\rbrack_{T} \cdot \left( \frac{V_{0}}{V_{0}\  + \ \frac{\text{Δ}V}{\text{Δ}t}T} \right)^{- {({1\  + \ \frac{3}{50} \cdot \frac{x}{\frac{\text{Δ}V}{\text{Δ}t}}})}}\  - \ \left\lbrack {Cr} \right\rbrack_{0}}} \right)\  - \ \frac{50}{3} \cdot \frac{\text{Δ}V}{\text{Δ}t}.$$With actual values entered, it equals:$$\frac{88}{3.49}\left( {1\  - \ \frac{3.49\  - \ 2.22}{3.49 \cdot \left( \frac{50.7}{53.9175} \right)^{- {({1\  + \ \frac{3}{50} \cdot \frac{x}{0.15}})}}\  - 2.22}} \right)\  - \ \frac{50}{3} \cdot 0.15.$$

It is desirable to have *GFR*~*K*~ in mL/min, which is accomplished by a unit conversion of $\frac{1,000\ \ \text{mL}}{\text{L}} \cdot \frac{\text{h}}{60\ \text{min}}$, giving rise to the $\frac{50}{3}$ factor. The graph ([Fig 2](#fig2){ref-type="fig"}) shows 2 intersection points at −2.5 and 10.104. The −2.5 is an extraneous solution and can be ignored. Basically, it is the negative of $\frac{\text{Δ}V}{\text{Δ}t}:\  - \frac{3.6\ \text{L}}{24\ \text{h}} \cdot \frac{1,000\ \text{mL}}{\text{L}} \cdot \frac{\text{h}}{60\ \text{min}}\  = - 2.5\ \frac{\text{mL}}{\text{min}}$.[@bib3], [@bib4] The real GFR~K~ is the 10.104 mL/min. This compares plausibly with the erroneous steady-state GFR for when the patient's \[*Cr*\] = 3.49 mg/dL that could be calculated as *Gen*/\[*Cr*\] = 88/3.49 ≈ 25 mL/min.Figure 2Graph of the gold standard way to find the kinetic glomerular filtration rate (GFR~K~). Equation [(7)](#fd7){ref-type="disp-formula"} cannot be rearranged to provide an explicit solution for GFR~K~. However, the equality between the 2 sides of the equation means that they can be graphed separately and the intersection point(s) will provide the answer. The left-hand side is simply the line *y* = *x* and is shown as the diagonal blue line. The right-hand side is the more complicated portion (see text for details) and is shown as the purple curve. The line and curve intersect at 2 places. The 10.104 is the real GFR~K~. The −2.5 is an extraneous value that can be disregarded.

Newton's Method {#sec2.6.2}
---------------

From equation [(7)](#fd7){ref-type="disp-formula"}, we find a function that equals zero when the real *GFR*~*K*~ is plugged in:$$f\ \left( {GFR_{K}} \right)\  = \ \frac{Gen}{\left\lbrack {Cr} \right\rbrack_{T}}\left( {1\  - \ \frac{\left\lbrack {Cr} \right\rbrack_{T}\  - \ \left\lbrack {Cr} \right\rbrack_{0}}{\left\lbrack {Cr} \right\rbrack_{T} \cdot \left( \frac{V_{0}}{V_{0}\  + \ \frac{\text{Δ}V}{\text{Δ}t}T} \right)^{- {({1\  + \ \frac{GFR_{K}}{\frac{\text{Δ}V}{\text{Δ}t}}})}}\  - \ \left\lbrack {Cr} \right\rbrack_{0}}} \right)\  - \ \frac{\text{Δ}V}{\text{Δ}t}\  - \ GFR_{K}.$$Differentiate *f*(*GFR*~*K*~) with respect to *GFR*~*K*~---all other variables are effectively constants---and then iteratively apply $GFR_{2}\  = \ GFR_{1}\  - \ \frac{f\ \left( {GFR_{1}} \right)}{f^{'}\left( {GFR_{1}} \right)}$ until the calculations stabilize at the correct kinetic GFR. See [Item S1](#appsec1){ref-type="sec"} for the Newton's method equation. With an initial guess of *GFR*~1~ = 3 mL/min, the *GFR*~2~ outputs stabilize after the seventh iteration ([Table 1](#tbl1){ref-type="table"}), so that the answer is 10.1043174912624..., shown to an unrealistic accuracy of decimal places to illustrate the convergence of the iterations. The value agrees well with the 10.104 found by graphing.Table 1Outputs of Newton's Method for the Gold Standard Equation [(7)](#fd7){ref-type="disp-formula"}Iteration No.Gold StandardGuess311190.538743092500000222.714899713418800312.296436181716700410.270468202660900510.105582472040500610.104317566510400**710.104317491262400**810.104317491262400910.104317491262400[^1]

Using the True Average \[Cr\] Equation {#sec2.7}
======================================

Graphing {#sec2.7.1}
--------

Replacing *GFR*~*K*~ with *x* in equation [(5)](#fd5){ref-type="disp-formula"}, we graph *y* = *x* for the left-hand side and then$$y\  = \ \frac{Gen \cdot T\  - \ \frac{50}{3}\left( {\left\lbrack {Cr} \right\rbrack_{T}V_{T}\  - \ \left\lbrack {Cr} \right\rbrack_{0}V_{0}} \right)}{\left\lbrack {Cr} \right\rbrack_{0}T\  + \ \left( {\frac{Gen}{x\  + \ \frac{50}{3} \cdot \frac{\text{Δ}V}{\text{Δ}t}}\  - \ \left\lbrack {Cr} \right\rbrack_{0}} \right)\left( {T\  - \ \frac{50}{3} \cdot \frac{V_{0}}{x} \cdot \left\lbrack {1\  - \ \left( \frac{V_{0}}{V_{0}\  + \ \frac{\text{Δ}V}{\text{Δ}t}T} \right)^{({\frac{3}{50} \cdot \frac{x}{\frac{\text{Δ}V}{\text{Δ}t}}})}} \right\rbrack} \right)}$$(which has unit conversions) for the right-hand side. With the clinical case values plugged in, it becomes$$y\  = \ \frac{88 \cdot 21.45\  - \ \frac{50}{3}\left( {3.49 \cdot 53.9175\  - \ 2.22 \cdot 50.7} \right)}{2.22 \cdot 21.45\  + \ \left( {\frac{88}{x\  + \ \frac{50}{3} \cdot 0.15}\  - \ 2.22} \right)\left( {21.45\  - \ \frac{50}{3} \cdot \frac{50.7}{x} \cdot \left\lbrack {1\  - \ \left( \frac{50.7}{53.9175} \right)^{({\frac{3}{50} \cdot \frac{x}{0.15}})}} \right\rbrack} \right)}$$

The graph shows only 1 intersection with *y* = *x* ([Fig 3](#fig3){ref-type="fig"}), as opposed to 2 intersections for the gold standard. The kinetic GFR is 10.104 mL/min, matching the gold standard.Figure 3Graph of the true average creatinine concentration (\[Cr\]) way to find the kinetic glomerular filtration rate (GFR~K~). Equation [(5)](#fd5){ref-type="disp-formula"} also does not have an explicit solution for GFR~K~, but it too can be graphed to find the answer as represented by an intersection point. The left-hand side of the equation is the same *y* = *x* diagonal blue line as in [Figure 2](#fig2){ref-type="fig"}. However, the right-hand side (see text for details), using GFR~K~ as the independent variable, appears as the black curvilinear segment. The blue line and black segment also intersect at 10.104, the same value obtained by the gold standard equation [(7)](#fd7){ref-type="disp-formula"}---superimposed here for reference (purple dashed curve). Equations [(5)](#fd5){ref-type="disp-formula"}---true average---and (7)---gold standard---will always yield the same answer for GFR~K~, as proved by the mathematics, but equation [(5)](#fd5){ref-type="disp-formula"} is not affected by an extraneous solution.

Newton's Method {#sec2.7.2}
---------------

Equation [(5)](#fd5){ref-type="disp-formula"} is amenable to Newton's method as well. Let $f\ \left( {GFR_{K}} \right)\  = \ \frac{Gen \cdot T\  - \ \left( {\left\lbrack {Cr} \right\rbrack_{T}V_{T} - \left\lbrack {Cr} \right\rbrack_{0}V_{0}} \right)}{\overline{P_{Cr}} \cdot T} - GFR_{K}$, find the derivative *f*^\'^(*GFR*~*K*~), and apply $GFR_{2} = GFR_{1} - \frac{f\left( {GFR_{1}} \right)}{f^{'}\left( {GFR_{1}} \right)}$. See [Item S1](#appsec1){ref-type="sec"} for the Newton's method equation. For a fair comparison with the gold standard, also start with a guess of *GFR*~1~=3 mL/min. The *GFR*~2~ outputs stabilize after the third iteration ([Table 2](#tbl2){ref-type="table"}), as opposed to the seventh iteration for the gold standard. The GFR~K~s are identical to the last decimal place shown ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}).Table 2Outputs of Newton's Method for the True Average \[Cr\] Equation [(5)](#fd5){ref-type="disp-formula"}Iteration No.True AverageGuess3110.086614275666200210.104317382767700**310.104317491262400**410.104317491262400510.104317491262400610.104317491262400710.104317491262400810.104317491262400910.104317491262400[^2]

True Average \[Cr\] Is Not at the Halfway Point of Either \[Cr\] or Time {#sec2.7.3}
========================================================================

Having corroborated the GFR~K~ (∼10.104 mL/min), we can plug it back into equation [(6)](#fd6){ref-type="disp-formula"} to calculate the true average \[*Cr*\], which is seen to be 2.894~⋯~ mg/dL. As expected, this is different from the mean, which is (2.22 + 3.49)/2 = 2.855 mg/dL. During the \[*Cr*\] trajectory, when is the true average attained? It occurs at ∼10.393 hours. Again, this is distinct from the temporal midpoint, which occurs at 21.45 *h*/2 = 10.725 *h*. Finally, the true average is not located where the tangent to the trajectory, or d\[*Cr\]~t~*/d*t*, is parallel to the average slope between the \[*Cr*\] end points, or (\[*Cr*\]~*T*~−\[*Cr*\]~0~)/*T*, recalling the mean value theorem. There are likely no shortcuts to the true average \[*Cr*\].

Maximum Increase in \[Cr\] Per Day {#sec2.8}
==================================

Equation [(5)](#fd5){ref-type="disp-formula"} should be homologous to the original algebraic GFR~K~ equation,[@bib2] but one variable, the maximum increase in \[*Cr*\] per day as if anephric, is notably absent. The prior algebraic equation written in the current terminology (without unit conversions) is:$$GFR_{K}\  = \ \frac{Gen}{\left\lbrack {Cr} \right\rbrack_{\text{Mean}}}\left( {1\  - \ \frac{\left\lbrack {Cr} \right\rbrack_{T}\  - \ \left\lbrack {Cr} \right\rbrack_{0}}{\text{Δ}\left\lbrack {Cr} \right\rbrack_{\text{Max}/\text{day}} \cdot T}} \right)$$

Is equation [(8)](#fd8){ref-type="disp-formula"} just a primitive version of equation [(5)](#fd5){ref-type="disp-formula"}? In the evolution of GFR~K~ equations, 2 new features were added: the true average \[*Cr*\] replaces mean \[*Cr*\], and the volume of distribution is allowed to change instead of remaining fixed. If both features are removed, does the present equation [(5)](#fd5){ref-type="disp-formula"} revert back to equation [(8)](#fd8){ref-type="disp-formula"}? Yes, and the detailed methods ([Item S1](#appsec1){ref-type="sec"}) show how. The maximum \[*Cr*\] increase is disguised within equation [(5)](#fd5){ref-type="disp-formula"} and is unmasked in the special case of a stable volume. Though the maximum increase has a physiologic equivalent in $\frac{Gen}{V_{0}}$, we either calculate that fraction or subjectively choose its value based on our clinical judgment.[@bib2] Nowadays, we can avoid a subjective maximum increase in favor of the total body water (*V*~0~) and the change rate in volume $\left( \frac{\text{Δ}V}{\text{Δ}t} \right)$. The latter is important because the resultant $V_{0} + \frac{\text{Δ}V}{\text{Δ}t}T$ serves as the updated *V*~0~ for the next contiguous pair of \[*Cr*\]s.

Application to Patient Care {#sec2.9}
===========================

The assessment of kidney function is arguably the primary job of a nephrologist. We first learned how to quantify clearance in the steady state, and that is succinctly and elegantly symbolized by the basic clearance equation. Then we learned how to track the clearance in the nonsteady state, even if \[*Cr*\] is changing rapidly, and that is codified by the GFR~K~ equation.[@bib2], [@bib3], [@bib4] Superficially, the 2 equations may appear to be distinct, but deep down they are intimately related. The current work proves that GFR~K~ can be unified with steady-state GFR under the overarching and truly fundamental law of $\text{CL}_{\text{cr}} = \frac{U_{Cr} \times V}{P_{Cr}}$.

The veracity and applicability of the fundamental clearance in the kinetic situation expands our toolbox to evaluate kidney function. To shoehorn creatinine kinetics into a *U*~*Cr*~×*V*/*P*~*Cr*~ framework, one could have reasoned that the \[*Cr*\] would hold constant over some period that is infinitesimally small, satisfying the limitation of having a single *P*~*Cr*~ to work with. Unfortunately, trying to measure in that fleeting moment the *U*~*Cr*~×*V* and the *P*~*Cr*~ simultaneously is impractical and imprecise.[@bib7], [@bib8] We demonstrated how *U*~*Cr*~×*V*/*P*~*Cr*~ can work on a macroscopic time scale that is convenient to the way we practice medicine. It frees one up to back calculate the *U*~*Cr*~×*V* through an algebraic argument, without needing to assay urine for the excretion rate. Further, this calculation is path-independent. It does not matter what tortuous route the \[*Cr*\] took between the end points; the end points contain the necessary information. Subsequently, the true average \[*Cr*\], or $\overline{P_{Cr}}$, is decoded by the calculus of equation [(6)](#fd6){ref-type="disp-formula"}, completing the clearance formula.

Aiding Clinical Decisions: Clinical Case {#sec2.10}
========================================

We used the GFR~K~ on the Nephrology consult service to guide patient management. A 74-year-old man with pancreatic adenocarcinoma was tolerating chemotherapy well. Two weeks before admission, his \[*Cr*\] was at its usual baseline of 1.10 mg/dL. He subsequently presented with oligoanuria and a \[*Cr*\] of 8.64 to 9.57 mg/dL. He was initiated emergently on hemodialysis. Several days later, kidney biopsy revealed acute interstitial nephritis, and 7 days after admission, high-dose corticosteroid treatment was initiated. In the setting of ongoing intermittent hemodialysis, the \[*Cr*\]s ([Fig 4](#fig4){ref-type="fig"}) became difficult to interpret.Figure 4Early recognition of kidney recovery. A man had developed drug-induced severe acute interstitial nephritis that was treated with inpatient hemodialysis and steroids. His daily creatinine concentrations (\[Cr\]s) are graphed in purple. Dialysis made the \[Cr\] fluctuate, but was the kidney function getting better on the steroid therapy? The \[Cr\] pattern was analyzed using the kinetic glomerular filtration rate (GFR~K~) that accommodates body volume changes, for better accuracy. Looking at the graph of GFR~K~s in blue, we see that the GFR~K~ spiked up if dialysis occurred in the past 24 hours and that the GFR~K~ dropped back down if dialysis did not occur. The latter GFR~K~ "valleys" (circled) represent the patient's own native kidney function. Focusing on the valleys, we observed no evidence of kidney recovery up until hospital day 6 when only dialysis was being done. When prednisone therapy was started on hospital day 7, the next GFR~K~ valley on day 8 already showed a hint of kidney function increase. This incipient kidney recovery became more established on subsequent days, allowing us to discontinue dialysis with confidence. The GFR~K~ reached ∼32.5 mL/min by discharge on day 15. As an outpatient, he was gradually weaned off prednisone, and 10 days after discharge a follow-up \[Cr\] had improved to 1.70 mg/dL.

The sawtooth \[*Cr*\] pattern, typical of dialysis, is shown in purple, while its translation into GFR~K~ is presented in blue ([Fig 4](#fig4){ref-type="fig"}). On dialysis days, the GFR~K~ spiked up, but on nondialysis days, the GFR~K~ decreased to ∼6 mL/min consistently, indicative of a "native" kidney function that was not yet recovering. The first opportunity to measure the GFR~K~ off dialysis was on hospital day 8, when it had increased to ∼9 mL/min. We were cautiously optimistic about the effect of the steroids. The next native GFR~K~ came on hospital day 10, and it improved to ∼15 mL/min. Dialysis was skipped, and by the morning of hospital day 11, the GFR~K~ increased further to ∼17 mL/min. Although the prednisone seemed to be working, one last dialysis was done on hospital day 11, causing the GFR~K~ to spike up on hospital day 12. The last few GFR~K~s were off dialysis but kept increasing, so it was clear that the patient's kidneys were recovering. The clearance increased to ∼32.5 mL/min by discharge on hospital day 15. Thus, GFR~K~ analysis detected kidney recovery soon after treatment for nephritis was begun. A kinetic GFR calculator is available as online supplementary material ([Supplementary File 2](#appsec1){ref-type="sec"}).

Versatility {#sec2.11}
===========

The true average concept could also prove to be versatile. A \[*Cr*\] trajectory may defy mathematical modeling, but if we suspect that the evolution of \[*Cr*\] is still governed by the principle of mass balance, just in a complicated way, the inability to construct an accurate differential equation may not matter so much. We can infer the true average \[*Cr*\] by other means. One way might be to assay the plasma \[*Cr*\] frequently, or continuously if the technology allows, so as to finely trace the \[*Cr*\] trajectory. Then numerical techniques can be used to deduce where the horizontal line must be drawn such that the signed areas above/below the \[*Cr*\] curve sum to zero, as in [Figure 1](#fig1){ref-type="fig"}. The proof by the fundamental theorem of calculus ensures that an average \[*Cr*\] obtained in this way would be valid. One uncertainty with this approach is whether the creatinine generation rate is constant. However, if we can describe how the *Gen* changes as a function of time, that is, a *Gen*~*t*~, then the added creatinine is quantified by $\int_{0}^{T}{Gen_{t}\text{d}t}$ and is used to solve for *U*~*Cr*~×*V*.

If the \[*Cr*\] is measured frequently, that would permit the GFR~K~ to be tracked more closely. For now, the mass balance differential equation treats *GFR*~*K*~ as having a single constant value on the interval between 2 \[*Cr*\]s. Therefore, *GFR*~*K*~ is the average clearance for that time. Because the \[*Cr*\] laboratory tests are typically drawn daily, the real-time change in GFR~K~ cannot be discerned. To approximate real time, the shortest time for the most severe AKI to exceed a \[*Cr*\] error threshold of 3% is about 10 to 20 minutes. Checking the \[*Cr*\] that frequently is likely impractical, notwithstanding the \[*Cr*\] assay lag time.

Limitations {#sec2.12}
===========

GFR is not synonymous with CL~cr~. The former refers to clearance done by the glomeruli, whereas the latter refers to clearance done by all routes. Although glomerular clearance is usually predominant, the additional nonglomerular routes include diffusion into the gut, degradation by bacterial creatininases, and, most importantly, renal tubular secretion of creatinine.[@bib9], [@bib10], [@bib11], [@bib12] Technically, equation [(5)](#fd5){ref-type="disp-formula"} calculates the kinetic CL~cr~, and this overestimates the GFR~K~. One way to bring the kinetic CL~cr~ closer to the true GFR is to administer cimetidine to inhibit tubular secretion of creatinine,[@bib13] but this is not routinely done outside of clinical research. Another strategy is to change the assay from creatinine to inulin, which is freely filtered by glomeruli but not secreted or reabsorbed by tubules. However, inulin is expensive to infuse, even as a bolus, and difficult to measure.[@bib14] Behaving like inulin, an endogenous substance cystatin C might replace creatinine one day, but there is some extrarenal elimination and it is catabolized in the tubules with reabsorption of its metabolites.[@bib15] Nevertheless, the GFR~K~ equation can be adapted to work with cystatin C.[@bib16] Finally, the shortcomings that relate to the assumptions of the kinetic math model, such as a fixed creatinine generation rate or a linear rate of volume change, have been extensively detailed elsewhere.[@bib3], [@bib4]

Mean \[Cr\] Redux {#sec2.13}
=================

In the algebraic GFR~K~, the mean of the \[*Cr*\] end points was an approximation of the true average \[*Cr*\], which was not known in 2013, but the mean \[*Cr*\] seemed to work well enough. The original algebraic equation has been tested extensively in clinical research and has performed admirably.[@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], [@bib28] In 2018, the GFR~K~ equation was upgraded with calculus to accommodate a volume that changes steadily.[@bib3] To remodel the algebraic into a calculus version, we had to figure out the exact substitute for the mean. Is this true average worth using to gain extra precision in the GFR~K~? The mean is close enough to the true average when the time is kept to about 24 hours between \[*Cr*\]s, as is routinely done in the hospital. Plus, the mean is easier to use on rounds. The mean \[*Cr*\] would give a GFR~K~ of 10.243 mL/min for the first clinical case, which compares favorably with the 10.104 mL/min. However, the mean \[*Cr*\] should not be used in place of the true average when the \[*Cr*\] trajectory is significantly curved, such as in [Figure 1](#fig1){ref-type="fig"}. The nonlinearity can become more pronounced over a longer period. Insisting on the true average \[Cr\] requires higher mathematics, and the added effort could decrease the method's adoption rate. Fortunately, the tedium of computation can be handled by computers. Clinical laboratories could even program in Newton's method to report the GFR~K~s, as is already done with estimated GFRs like the MDRD (Modification of Diet in Renal Disease) Study equation or the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation.[@bib29], [@bib30]

Generalizable? {#sec2.14}
==============

The fundamental law of clearance really does apply beyond the steady state. We now have a general strategy to handle the more complex \[*Cr*\] trajectories that occur in real life. For example, AKI due to sepsis may entail a reduction in creatinine generation rate that will suppress an increase in \[*Cr*\] and mask the severity of AKI.[@bib31] However, if the change in *Gen* is accounted for in the *U*~*Cr*~×*V* and in the true average \[*Cr*\], the resulting *GFR*~*K*~ will reflect the real extent of kidney function loss. Still, it remains to be seen whether the true average paradigm can be applied more universally to the continuous but non-smooth \[*Cr*\] functions that violate differential equation [(1)](#fd1){ref-type="disp-formula"}. In the meantime, the true average \[*Cr*\] concept may open up more avenues to explore in the field of GFR~K~.
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**Item S1:** Detailed methods.
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Kinetic GFR Calculator

[^1]: *Note:* The calculations stabilize by iteration 7.

[^2]: *Note:* Calculations stabilize by iteration 3, giving the same answer as in [Table 1](#tbl1){ref-type="table"}.
